Search Results
AR42 25 mg | 99.46%
TargetMol
AR42 10 mg | 99.46%
TargetMol
(E/Z)-BIX02188 5 mg | 99.21%
TargetMol
BIX02188 is a specific MEK5 inhibitor (IC50: 4.3 nM), also inhibits ERK5 catalytic activity (IC50: 810 nM), and does not inhibit closely related kinases MEK1/2, JNK2, and ERK2.
More Information Supplier Page(E/Z)-BIX02188 2 mg | 99.21%
TargetMol
BIX02188 is a specific MEK5 inhibitor (IC50: 4.3 nM), also inhibits ERK5 catalytic activity (IC50: 810 nM), and does not inhibit closely related kinases MEK1/2, JNK2, and ERK2.
More Information Supplier PageDisufenton sodium 5 mg | 99.00%
TargetMol
Disufenton sodium (NXY-059), a new-type nitrone, exhibits potently neuroprotective effects.
More Information Supplier PageDisufenton sodium 50 mg | 99.00%
TargetMol
Disufenton sodium (NXY-059), a new-type nitrone, exhibits potently neuroprotective effects.
More Information Supplier PageDisufenton sodium 25 mg | 99.00%
TargetMol
Disufenton sodium (NXY-059), a new-type nitrone, exhibits potently neuroprotective effects.
More Information Supplier PageDisufenton sodium 10 mg | 99.00%
TargetMol
Disufenton sodium (NXY-059), a new-type nitrone, exhibits potently neuroprotective effects.
More Information Supplier PagePF-562271 besylate 5 mg | 99.50%
TargetMol
PF-562271 (besylate) is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs.
More Information Supplier Page